H2AX and neoplasm: We confirmed on-target drug activity in vivo at these pharmacologically relevant dosages using TOP2cc formation and γ-H2AX as pharmacodynamic markers, interrogated using a RADAR assay (Fig. 7A and Fig. S7D), and immunoblotting respectively (Fig. 7B), using PDX tumor tissue harvested from CX-5461 treated mice.